2017
DOI: 10.3892/etm.2017.5404
|View full text |Cite
|
Sign up to set email alerts
|

Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor‑κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis

Abstract: Atherosclerosis is a chronic inflammatory disease, which is triggered by lipid retention. Toll-like receptor 2 (TLR2) is a novel target for therapeutic intervention in atherosclerosis. In addition, nuclear factor-κB (NF-κB) serves important roles in stress response and inflammation. The present study investigated whether TLR2 is involved in the activation of cholesterol efflux in macrophages by regulating the NF-κB pathway. The human monocytic THP-1 cell line and murine macrophage RAW264.7 cell line were treat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 43 publications
0
9
0
Order By: Relevance
“…Basically, oxLDL is a principle component of endogenous lipid ligand that causes endothelial cell injury, accumulates in macrophage and VSMCs and induces a cellular in ammation response [25,26]. Tlrs were reported to participate in oxLDL induced in ammation response [27][28][29], but an integrated expression feature of Tlrs family in VSMCs under oxLDL stimulation remained unelaborated. In our present study, we found that oxLDL raised the expression of Tlr4 more signi cantly, which was over 1.5-fold than other Tlrs in VSMCs.…”
Section: Discussionmentioning
confidence: 99%
“…Basically, oxLDL is a principle component of endogenous lipid ligand that causes endothelial cell injury, accumulates in macrophage and VSMCs and induces a cellular in ammation response [25,26]. Tlrs were reported to participate in oxLDL induced in ammation response [27][28][29], but an integrated expression feature of Tlrs family in VSMCs under oxLDL stimulation remained unelaborated. In our present study, we found that oxLDL raised the expression of Tlr4 more signi cantly, which was over 1.5-fold than other Tlrs in VSMCs.…”
Section: Discussionmentioning
confidence: 99%
“…Here, toll-like receptors (TLRs) represent PRRs being either present on the PM or within endosomes majorly recognizing nucleic acids ( Latz et al, 2004 ; Nishiya et al, 2005 ; Husebye et al, 2006 ; Johnsen et al, 2006 ; Nilsen et al, 2008 ; Ishii et al, 2014 ; Lester and Li, 2014 ). They share a close relationship with ABCA1-dependent cholesterol removal, which interferes with downstream cascades and vice versa ( Zhu et al, 2008 , 2010 ; Guo et al, 2015 ; Li et al, 2018 ; Ding et al, 2020 ). Similarly, TLR activity seems to decline upon application of statins, inhibitors of cholesterol synthesis ( Mullen et al, 2015 ; Bahrami et al, 2018 ; Venardos et al, 2018 ).…”
Section: Innate Immunitymentioning
confidence: 99%
“…A recent study has shown that NF-κB activation may be associated with ABCA1 expression and cholesterol e ux in macrophages [9]. In our study, we found that NF-κB signaling activation inhibitors signi cantly blocked ox-LDL inhibition of ABCA1 expression and increased cholesterol e ux in macrophage-derived foam cells, which suggests that under ox-LDL treatment, NF-κB signal acts as the upstream of ABCA1 and is activated by ox-LDL to inhibit the expression of ABCA1, impeding the reverse cholesterol transport, and aggravating the degree of cell foaming.…”
Section: Discussionmentioning
confidence: 99%